SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-328326
Filing Date
2013-08-09
Accepted
2013-08-09 10:01:20
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d561297d10q.htm 10-Q 340650
2 EX-31.1 d561297dex311.htm EX-31.1 9927
3 EX-31.2 d561297dex312.htm EX-31.2 10005
4 EX-32.1 d561297dex321.htm EX-32.1 2825
5 EX-32.2 d561297dex322.htm EX-32.2 3116
  Complete submission text file 0001193125-13-328326.txt   4496500

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT alse-20130630.xml EX-101.INS 336037
7 XBRL TAXONOMY EXTENSION SCHEMA alse-20130630.xsd EX-101.SCH 38736
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alse-20130630_cal.xml EX-101.CAL 60605
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alse-20130630_def.xml EX-101.DEF 107667
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE alse-20130630_lab.xml EX-101.LAB 327221
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alse-20130630_pre.xml EX-101.PRE 213580
Mailing Address 239 SOUTH STREET HOPKINTON MA 01748
Business Address 239 SOUTH STREET HOPKINTON MA 01748 508-497-2360
ALSERES PHARMACEUTICALS INC /DE (Filer) CIK: 0000094784 (see all company filings)

IRS No.: 870277826 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-06533 | Film No.: 131024790
SIC: 2834 Pharmaceutical Preparations